Oxidative stress in human immunodeficiency virus infection

被引:103
作者
Israël, N
Gougerot-Pocidalo, MA
机构
[1] Inst Pasteur, Unite Biol Retrovirus, F-75724 Paris 15, France
[2] Hop Bichat Claude Bernard, INSERM, U294, F-75018 Paris, France
关键词
oxidative stress; HIV infection; HIV replication; HIV transcription; antioxidants;
D O I
10.1007/s000180050106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infection by the human immunodeficiency virus (HIV-1) causes chronic ongoing inflammation in HIV-1 seropositive individuals as shown by high plasma levels of inflammatory cytokines and production of reactive oxygen intermediates (ROIs). One source of ROIs is provided from the very early stages of HIV infection by activated polymorphonuclear neutrophils. Tat, the viral protein. is also specifically responsible for an endogenous cellular increase of ROI. In this review we also evaluate the effects of this oxidative stress on various biological parameters such as immune response and survival of T lymphocytes, virus transcription and replication. It was clearly demonstrated in ex vivo experiments that the oxidative stress due to infection itself participates in CD4(+) T lymphocyte depletion by increasing their rate of apoptosis and particularly of Fas-induced apoptosis. This oxidative stress also facilitates NF-kappa B-dependent activation of HIV transcription. In vitro studies suggest that the early steps of HIV activation from its quiescent state might be subsequently facilitated by this oxidative environment, whereas already active replication is not influenced. The data presented here lead to a better understanding of the consequences of oxidative stress on the pathophysiology of HIV infection and also enable us to evaluate the potential use of antioxidant molecules as therapeutic agents against AIDS.
引用
收藏
页码:864 / 870
页数:7
相关论文
共 55 条
[1]   APPRAISAL OF POTENTIAL THERAPEUTIC INDEX OF ANTIOXIDANTS ON THE BASIS OF THEIR IN-VITRO EFFECTS ON HIV REPLICATION IN MONOCYTES AND INTERLEUKIN 2-INDUCED LYMPHOCYTE-PROLIFERATION [J].
AILLET, F ;
GOUGEROTPOCIDALO, MA ;
VIRELIZIER, JL ;
ISRAEL, N .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) :405-411
[2]   FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
TOUGH, TW ;
DAVISSMITH, T ;
BRADDY, S ;
FALK, B ;
SCHOOLEY, KA ;
GOODWIN, RG ;
SMITH, CA ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :71-77
[3]  
AMEISEN JC, 1992, CR ACAD SCI III-VIE, V314, P47
[4]   HIV ENHANCER ACTIVITY PERPETUATED BY NF-KAPPA-B INDUCTION ON INFECTION OF MONOCYTES [J].
BACHELERIE, F ;
ALCAMI, J ;
ARENZANASEISDEDOS, F ;
VIRELIZIER, JL .
NATURE, 1991, 350 (6320) :709-712
[5]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[6]  
Boudet F, 1996, J IMMUNOL, V156, P2282
[7]   CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS [J].
BRUNNER, T ;
MOGIL, RJ ;
LAFACE, D ;
YOO, NJ ;
MAHBOUBI, A ;
ECHEVERRI, F ;
MARTIN, SJ ;
FORCE, WR ;
LYNCH, DH ;
WARE, CF ;
GREEN, DR .
NATURE, 1995, 373 (6513) :441-444
[8]   GLUTATHIONE DEFICIENCY AND HIV [J].
BUHL, R ;
JAFFE, HA ;
HOLROYD, KJ ;
WELLS, FB ;
MASTRANGELI, A ;
SALTINI, C ;
CANTIN, AM ;
CRYSTAL, RG .
LANCET, 1990, 335 (8688) :546-546
[9]  
CHAUDHRI G, 1986, J IMMUNOL, V137, P2646
[10]   Thiol-mediated inhibition of FAS and CD2 apoptotic signaling in activated human peripheral T cells [J].
Deas, O ;
Dumont, C ;
Mollereau, B ;
Metivier, D ;
Pasquier, C ;
BernardPomier, G ;
Hirsch, F ;
Charpentier, B ;
Senik, A .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (01) :117-125